相关实验视频
Updated: Jan 14, 2026

12:19
Three-Dimensional 3D Tumor Spheroid Invasion Assay
Published on: May 1, 2015
59.4K
在头部和部状细胞癌中,TWF1通过AKT酸化促进瘤的进展
Yingshun Yang1, Kaicheng Yang2, Shixiong Peng2
1Department of Oral and Maxillofacial Surgery, Hebei Eye Hospital, Xingtai, Hebei 054000, China.
Archives of oral biology
|October 23, 2025
概括
双林氨酸结合蛋白1 (TWF1) 通过激活AKT通路,驱动头部和部状细胞癌 (HNSCC) 的进展. 针对TWF1可能为HNSCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 双胞胎蛋白活性蛋白结合蛋白1 (TWF1) 涉及到细胞过程.
- 它在头部和部状细胞癌 (HNSCC) 恶性瘤中的作用尚未完全理解.
研究的目的:
- 阐明TWF1对HNSCC进展作出贡献的分子机制.
- 研究TWF1作为HNSCC的潜在治疗点.
主要方法:
- 对TWF1表达和预后价值的TCGA数据集进行全癌症分析.
- 定量实时PCR (qPCR) 和免疫组织化学 (IHC) 用于在HNSCC组织中验证.
- 在体外功能测定 (增殖,迁移,入侵) 用TWF1敲击 (siRNA) 和过度表达.
- 西部斑点分析和救援实验,以评估AKT信号通路的参与.
主要成果:
- 在HNSCC和其他12种癌症类型中,TWF1被上调,与晚期T阶段和淋巴结转移相关.
- 抑制TWF1抑制了HNSCC细胞的增殖,迁移和入侵,而TWF1过度表达促进了这些恶性表型.
- TWF1调节AKT酸化,其对HNSCC进展的影响部分通过这种途径进行介导.
结论:
- 在HNSCC中,TWF1充当瘤驱动剂,通过AKT信号通路促进瘤的进展.
- 在HNSCC中,TWF1代表了准确医学的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

